Louisiana Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on October 16, 2025

October 16, 2025

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire

October 16, 2025

PetVivo Animal Health, Inc. Enters Vendor Partner Agreement with Veterinary Growth Partners to Expand Access to Innovative Veterinary Therapeutics

GlobeNewswire

October 16, 2025

Vor Bio Announces Publication of China Phase 3 Study of Telitacicept in Systemic Lupus Erythematosus in The New England Journal of Medicine

GlobeNewswire

October 16, 2025

Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone

GlobeNewswire

October 16, 2025

Belite Bio to Participate in the 2025 Maxim Growth Summit

GlobeNewswire

October 16, 2025

LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities, Including Ongoing Advancement of Lead Candidate LB-100, Strategic Oncology Business Development and Acquisition Plans

GlobeNewswire

October 16, 2025

Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

October 16, 2025

Aptose’s Tuspetinib Exceeds Expectations When Combined with Standard of Care Treatment Across Diverse Populations of Newly Diagnosed AML

GlobeNewswire

October 16, 2025

C4 Therapeutics Announces Pricing of $125 Million Underwritten Offering

GlobeNewswire

October 16, 2025

Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October 30 at 8:00 a.m. ET

GlobeNewswire

October 16, 2025

Conavi Medical to Present at the Planet MicroCap Showcase: TORONTO in partnership with MicroCapClub on Wednesday, October 22, 2025

GlobeNewswire

October 16, 2025

Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 Financial Results

GlobeNewswire

October 16, 2025

National PKU Alliance Grant Advances Engineered Native Bacteria Candidate for Phenylketonuria (PKU)

GlobeNewswire

October 16, 2025

Foghorn Therapeutics Announces Significant Progress for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit

GlobeNewswire

October 16, 2025

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

October 16, 2025

Ligand to Host Investor Day on December 9, 2025

GlobeNewswire

October 16, 2025

BPGbio Presents Phase 2 Glioblastoma Data on BPM31510 at ESMO 2025

GlobeNewswire

October 16, 2025

Dianthus Therapeutics Announces Exclusive License Agreement with Leads Biolabs for DNTH212, a First and Potentially Best-In-Class, Phase 1 Ready Bifunctional BDCA2 & BAFF/APRIL Inhibitor for Severe Autoimmune Diseases

GlobeNewswire

October 16, 2025

Praxis Precision Medicines Announces Positive Topline Results from Two Pivotal Phase 3 Studies of Ulixacaltamide HCl in the Essential3 Program for Essential Tremor

GlobeNewswire

October 16, 2025

Gain Therapeutics to Attend the 2025 Maxim Growth Summit

GlobeNewswire